Viewing Study NCT02036060


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2026-01-05 @ 2:30 AM
Study NCT ID: NCT02036060
Status: COMPLETED
Last Update Posted: 2020-11-16
First Post: 2014-01-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer.
Sponsor: Spanish Oncology Genito-Urinary Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module